Showing 8111-8120 of 8791 results for "".
- Meet the Neocutis' Family's Newest Add: Micro-Firm Neck and Décolleté Rejuvenating Complexhttps://practicaldermatology.com/news/meet-the-neocutis-familys-newest-add-micro-firm-neck-and-dcollet-rejuvenating-complex/2458723/Neocutis’ Micro-Firm Neck and Décolleté Rejuvenating Complex is slated to hit physician’s offices in March 2016. The cream, which will be the newest addition to the Neocutis family of anti-aging products, targets the delicate
- New Sunscreen Blocks UV Rays, Boosts Vitamin Dhttps://practicaldermatology.com/news/new-sunscreen-blocks-rays-boosts-vitamin-d/2458724/A new sunscreen may do more than block ultraviolet radiation, it may also allow the body to produce vitamin D. The sunscreen, Solar D, is currently available in Australia and will be available in the U.S. in summer 2016.The
- Valeant: FDA Accepts BLA for Brodalumabhttps://practicaldermatology.com/news/valeant-fda-accepts-bla-for-brodalumab/2458726/The FDA has accepted for review the Biologics License Application (BLA) submitted by AstraZeneca in partnership with Valeant, for brodalumab injection, 210mg, a monoclonal antibody that targets the IL-17 receptor, in development for patients with moderate-to-severe plaque psoriasis. The FDA has a
- Rosacea, Glioma Linked: Are MMPs the Common Denominator?https://practicaldermatology.com/news/rosacea-glioma-linked-are-mmps-the-common-denominator/2458730/Rosacea may increase risk for glioma, according to a nationwide cohort study in Denmark. The findings, published online in JAMA Dermatology, suggest that an increased focus on neurologic sympt
- Vyome Biosciences: FDA Has Accepted IND for Investigational Acne Therapyhttps://practicaldermatology.com/news/vyome-biosciences-fda-has-accepted-ind-for-investigational-acne-therapy/2458728/The FDA has accepted from Vyome Biosciences an Investigational New Drug (IND) Application for the initiation of clinical studies for its lead program VB 1953, a topical therapeutic candidate for the treatment of moderate-to-severe acne. Vyome plans to start the Phase I clinical trials very soon.<
- Dr. Andrew Krakowski Now CMO at DermOnehttps://practicaldermatology.com/news/andrew-krakowski-now-cmo-at-dermone/2458729/Andrew C. Krakowski, MD has joined DermOne, a network of comprehensive dermatology practices, as Chief Medical Officer. “The need for dermatology services has accelerated in recent years, due to an aging population, a growing demand for surgical and cosmetic procedures and a raised
- Bristol-Myers Squibb's Opdivo + Yervoy Regimen Receives Expanded FDA Approval in Unresectable or Metastatic Melanoma Across BRAF Statushttps://practicaldermatology.com/news/bristol-myers-squibbs-opdivo-yervoy-regimen-receives-expanded-fda-approval-in-unresectable-or-metastatic-melanoma-across-braf-status/2458732/The FDA has approved Bristol-Myers Squibb’s Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the treatment of patients with BRAF V600 wild-type and BRAF V600 mutation-positive unresectable or metastatic melanoma. This indication is
- New Web Tool May Curb Indoor Tanning Use Among Coedshttps://practicaldermatology.com/news/new-web-tool-may-curb-indoor-tanning-use-among-coeds/2458737/A web-based intervention that taps into indoor tanning users’ perceptions about the value of tanning may help curb tanning bed use among young females, suggests research out of Rutgers Cancer Institute of New Jersey in New Brunswick. Research has shown that some indoor tanners do so
- Study: MD Complete Holds Its Own Against Two Rx Skincare Regimenshttps://practicaldermatology.com/news/md-complete-holds-own-against-two-rx-skincare-regimens/2458736/A new split-face study suggests that a mass marketed skin care system can hold its own against two prescription skin care regimens when it comes to improving photoaged skin. The new findings, which compared MD Complete with two professi
- DERMAFLASH® Brings Benefits of Dermaplaning Homehttps://practicaldermatology.com/news/dermaflash-brings-benefits-of-dermaplaning-home/2458738/DERMAFLASH™ is the newest addition to the DIY beauty device market. Designed specifically for women, the noninvasive exfoliation device is based on the principles of dermaplaning. DERMAFLASH uses sonic vibration to sweep away dead skin cells, vellus and even coarser